We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Harnessing the Immune System Against Cancer by Targeting CD25
Video

Harnessing the Immune System Against Cancer by Targeting CD25

Harnessing the Immune System Against Cancer by Targeting CD25
Video

Harnessing the Immune System Against Cancer by Targeting CD25

Credit: CRUK

The shared CD25 activation mechanism on regulatory and effector T cells has been a big challenge when designing immunotherapy drugs. Cancer Research UK scientists from University College London in collaboration with Roche, have developed a new antibody that can target CD25 specifically on regulatory T cells while leaving effector T cells intact. Watch this antibody in action in this short animation.

Read the Nature paper on this area of research here.  


Advertisement